A cross-sectional study will be conducted among 300 schoolchildren in the Banfora region, including 120 in urban and 180 in rural areas, to assess the prevalence of schistosomiasis and soil-transmitted helminth infections. All children with S. mansoni and/or S. haematobium infections at enrolment will then be treated with dihydroartemisinin-piperaquine (DP) and followed up on days 1, 2, 3, 4, 28, and 42 to assess the efficacy and safety of DP. At the end of the study, all children (infected and uninfected) will receive praziquantel and albendazole according to national recommendations.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Prevalence of schistosomiasis and soil-transmitted helminth (STH) infections
Timeframe: January 2025
Intensity of S. mansoni and soil-transmitted helminth (STH) infections
Timeframe: January 2025
Intensity of S. haematobium infection
Timeframe: January 2025
Risk factors associated with schistosomiasis and soil-transmitted helminth infections
Timeframe: January 2025